Karyopharm Therapeutics Inc (KPTI) Actualités

Karyopharm Announces 1-for-15 Reverse Stock Split

Karyopharm Announces 1-for-15 Reverse Stock Split PR Newswire NEWTON, Mass., Feb. 24, 2025 NEWTON, Mass., Feb...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Karyopharm Reports Fourth Quarter and Full Year 2024 Financial Results, Announces Update to Phase 3 XPORT-EC-042 Trial and Highlights Recent Company Progress

Karyopharm Reports Fourth Quarter and Full Year 2024 Financial Results, Announces Update to Phase 3...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Karyopharm to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

Karyopharm to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 PR...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire NEWTON...

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Karyopharm Announces Preliminary Unaudited 2024 Revenue and 2025 Objectives

Karyopharm Announces Preliminary Unaudited 2024 Revenue and 2025 Objectives PR Newswire NEWTON, Mass., Jan...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities